Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Sep 2021. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4636100015 | Mosapride citrate | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 4636101016 | Mosapride citrate (substance) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Mosapride citrate | Is a | Gastrointestinal agent | true | Inferred relationship | Existential restriction modifier | ||
| Mosapride citrate | Is a | Substance with benzamide structure | true | Inferred relationship | Existential restriction modifier | ||
| Mosapride citrate | Is a | Substance with serotonin 5-hydroxytryptamine-4 receptor agonist mechanism of action (substance) | true | Inferred relationship | Existential restriction modifier | ||
| Mosapride citrate | Has disposition | Serotonin 5-hydroxytryptamine-4 receptor agonist | true | Inferred relationship | Existential restriction modifier | ||
| Mosapride citrate | Is modification of | Mosapride | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely mosapride citrate 5 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Mosapride citrate | Inferred relationship | Existential restriction modifier | 1 |
| Product containing precisely mosapride citrate 5 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | True | Mosapride citrate | Inferred relationship | Existential restriction modifier | 1 |
This concept is not in any reference sets
FHIR